25 XP   0   0   10

BIOLASE Inc
Buy, Hold or Sell?

Let's analyse Biolase together

PenkeI guess you are interested in BIOLASE Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BIOLASE Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BIOLASE Inc

I send you an email if I find something interesting about BIOLASE Inc.

Quick analysis of Biolase (30 sec.)










What can you expect buying and holding a share of Biolase? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
22.5%

What is your share worth?

Current worth
$0.31
Expected worth in 1 year
$-0.11
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.40
Return On Investment
-211.5%

For what price can you sell your share?

Current Price per Share
$0.19
Expected price per share
$0.1251 - $1.27
How sure are you?
50%

1. Valuation of Biolase (5 min.)




Live pricePrice per Share (EOD)

$0.19

Intrinsic Value Per Share

$-9.74 - $-8.24

Total Value Per Share

$-9.43 - $-7.94

2. Growth of Biolase (5 min.)




Is Biolase growing?

Current yearPrevious yearGrowGrow %
How rich?$5.8m$20.3m-$13.7m-209.4%

How much money is Biolase making?

Current yearPrevious yearGrowGrow %
Making money-$6.2m-$6m-$278.5k-4.4%
Net Profit Margin-50.5%-51.3%--

How much money comes from the company's main activities?

3. Financial Health of Biolase (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#256 / 340

Most Revenue
#183 / 340

Most Profit
#244 / 340

Most Efficient
#214 / 340

What can you expect buying and holding a share of Biolase? (5 min.)

Welcome investor! Biolase's management wants to use your money to grow the business. In return you get a share of Biolase.

What can you expect buying and holding a share of Biolase?

First you should know what it really means to hold a share of Biolase. And how you can make/lose money.

Speculation

The Price per Share of Biolase is $0.1911. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biolase.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biolase, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.31. Based on the TTM, the Book Value Change Per Share is $-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biolase.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.24-125.1%-0.32-164.8%-0.32-165.4%-0.31-162.0%-0.28-145.4%
Usd Book Value Change Per Share-0.08-39.7%-0.10-54.3%-0.21-112.2%-0.03-14.2%0.00-2.5%
Usd Dividend Per Share0.000.0%0.001.5%0.016.7%0.1472.7%0.0736.4%
Usd Total Gains Per Share-0.08-39.7%-0.10-52.9%-0.20-105.5%0.1158.5%0.0633.9%
Usd Price Per Share1.86-0.72-1.94-1.03-1.28-
Price to Earnings Ratio-1.95--0.65--1.50--1.12--1.44-
Price-to-Total Gains Ratio-24.50--6.48-15.54--1.97--1.83-
Price to Book Ratio6.07-2.37-2.01-2.61-2.47-
Price-to-Total Gains Ratio-24.50--6.48-15.54--1.97--1.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1911
Number of shares5232
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.14
Usd Book Value Change Per Share-0.10-0.03
Usd Total Gains Per Share-0.100.11
Gains per Quarter (5232 shares)-528.58584.58
Gains per Year (5232 shares)-2,114.332,338.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
159-2173-21242908-5702328
2118-4347-42385816-11404666
3177-6520-63528724-17097004
4237-8694-846611632-22799342
5296-10867-1058014541-284911680
6355-13041-1269417449-341914018
7414-15214-1480820357-398816356
8473-17388-1692223265-455818694
9532-19561-1903626173-512821032
10591-21735-2115029081-569823370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%19.0104.00.015.4%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%12.028.00.030.0%47.071.05.038.2%
Dividend per Share1.00.03.025.0%8.00.04.066.7%9.00.011.045.0%9.00.031.022.5%16.00.0107.013.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%13.027.00.032.5%48.070.05.039.0%

Fundamentals of Biolase

About BIOLASE Inc

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Fundamental data was last updated by Penke on 2024-03-20 11:27:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BIOLASE Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biolase earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • A Net Profit Margin of -42.0% means that $-0.42 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BIOLASE Inc:

  • The MRQ is -42.0%. The company is making a huge loss. -2
  • The TTM is -50.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-42.0%TTM-50.5%+8.5%
TTM-50.5%YOY-51.3%+0.8%
TTM-50.5%5Y-56.8%+6.3%
5Y-56.8%10Y-47.2%-9.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.0%-11.0%-31.0%
TTM-50.5%-20.2%-30.3%
YOY-51.3%-14.0%-37.3%
5Y-56.8%-19.5%-37.3%
10Y-47.2%-23.8%-23.4%
1.1.2. Return on Assets

Shows how efficient Biolase is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • -11.8% Return on Assets means that Biolase generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BIOLASE Inc:

  • The MRQ is -11.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-16.0%+4.1%
TTM-16.0%YOY-12.4%-3.6%
TTM-16.0%5Y-13.1%-2.8%
5Y-13.1%10Y-12.3%-0.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.8%-3.1%-8.7%
TTM-16.0%-4.2%-11.8%
YOY-12.4%-4.0%-8.4%
5Y-13.1%-3.8%-9.3%
10Y-12.3%-4.1%-8.2%
1.1.3. Return on Equity

Shows how efficient Biolase is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • -78.0% Return on Equity means Biolase generated $-0.78 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BIOLASE Inc:

  • The MRQ is -78.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -104.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-78.0%TTM-104.4%+26.4%
TTM-104.4%YOY-32.7%-71.8%
TTM-104.4%5Y-109.2%+4.8%
5Y-109.2%10Y-70.3%-38.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-78.0%-3.5%-74.5%
TTM-104.4%-4.4%-100.0%
YOY-32.7%-4.7%-28.0%
5Y-109.2%-5.7%-103.5%
10Y-70.3%-6.2%-64.1%

1.2. Operating Efficiency of BIOLASE Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biolase is operating .

  • Measures how much profit Biolase makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • An Operating Margin of -38.7% means the company generated $-0.39  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BIOLASE Inc:

  • The MRQ is -38.7%. The company is operating very inefficient. -2
  • The TTM is -44.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-38.7%TTM-44.6%+5.8%
TTM-44.6%YOY-45.5%+0.9%
TTM-44.6%5Y-50.4%+5.9%
5Y-50.4%10Y-44.1%-6.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.7%-24.5%-14.2%
TTM-44.6%-14.9%-29.7%
YOY-45.5%-11.5%-34.0%
5Y-50.4%-17.1%-33.3%
10Y-44.1%-20.6%-23.5%
1.2.2. Operating Ratio

Measures how efficient Biolase is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are $1.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BIOLASE Inc:

  • The MRQ is 1.339. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.429. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.339TTM1.429-0.090
TTM1.429YOY1.453-0.024
TTM1.4295Y1.528-0.099
5Y1.52810Y1.450+0.077
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3391.454-0.115
TTM1.4291.452-0.023
YOY1.4531.434+0.019
5Y1.5281.432+0.096
10Y1.4501.366+0.084

1.3. Liquidity of BIOLASE Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biolase is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.40 means the company has $1.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BIOLASE Inc:

  • The MRQ is 1.404. The company is just able to pay all its short-term debts.
  • The TTM is 1.561. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.404TTM1.561-0.157
TTM1.561YOY3.135-1.574
TTM1.5615Y2.382-0.821
5Y2.38210Y2.223+0.160
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4042.789-1.385
TTM1.5612.793-1.232
YOY3.1353.586-0.451
5Y2.3823.492-1.110
10Y2.2233.450-1.227
1.3.2. Quick Ratio

Measures if Biolase is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • A Quick Ratio of 0.62 means the company can pay off $0.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BIOLASE Inc:

  • The MRQ is 0.617. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.621. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.617TTM0.621-0.004
TTM0.621YOY1.857-1.236
TTM0.6215Y1.394-0.773
5Y1.39410Y1.286+0.108
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6171.587-0.970
TTM0.6211.633-1.012
YOY1.8572.155-0.298
5Y1.3942.300-0.906
10Y1.2862.255-0.969

1.4. Solvency of BIOLASE Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biolase assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biolase to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.85 means that Biolase assets are financed with 84.8% credit (debt) and the remaining percentage (100% - 84.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BIOLASE Inc:

  • The MRQ is 0.848. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.835. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.848TTM0.835+0.013
TTM0.835YOY0.596+0.239
TTM0.8355Y0.756+0.079
5Y0.75610Y0.618+0.139
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8480.400+0.448
TTM0.8350.386+0.449
YOY0.5960.330+0.266
5Y0.7560.440+0.316
10Y0.6180.460+0.158
1.4.2. Debt to Equity Ratio

Measures if Biolase is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biolase to the Medical Devices industry mean.
  • A Debt to Equity ratio of 558.5% means that company has $5.58 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BIOLASE Inc:

  • The MRQ is 5.585. The company is unable to pay all its debts with equity. -1
  • The TTM is 5.234. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.585TTM5.234+0.351
TTM5.234YOY1.519+3.714
TTM5.2345Y7.617-2.383
5Y7.61710Y4.467+3.150
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5850.570+5.015
TTM5.2340.569+4.665
YOY1.5190.479+1.040
5Y7.6170.626+6.991
10Y4.4670.692+3.775

2. Market Valuation of BIOLASE Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biolase generates.

  • Above 15 is considered overpriced but always compare Biolase to the Medical Devices industry mean.
  • A PE ratio of -1.95 means the investor is paying $-1.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BIOLASE Inc:

  • The EOD is -0.200. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.945. Based on the earnings, the company is expensive. -2
  • The TTM is -0.652. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.200MRQ-1.945+1.745
MRQ-1.945TTM-0.652-1.293
TTM-0.652YOY-1.500+0.848
TTM-0.6525Y-1.119+0.467
5Y-1.11910Y-1.441+0.322
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.200-1.038+0.838
MRQ-1.945-1.216-0.729
TTM-0.652-1.757+1.105
YOY-1.500-2.588+1.088
5Y-1.119-1.553+0.434
10Y-1.441-1.463+0.022
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BIOLASE Inc:

  • The EOD is -0.331. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.222. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.010. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.331MRQ-3.222+2.891
MRQ-3.222TTM-1.010-2.212
TTM-1.010YOY-1.302+0.292
TTM-1.0105Y-1.288+0.278
5Y-1.28810Y-3.503+2.215
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.331-1.228+0.897
MRQ-3.222-1.746-1.476
TTM-1.010-2.961+1.951
YOY-1.302-6.157+4.855
5Y-1.288-4.928+3.640
10Y-3.503-5.626+2.123
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biolase is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 6.07 means the investor is paying $6.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BIOLASE Inc:

  • The EOD is 0.623. Based on the equity, the company is cheap. +2
  • The MRQ is 6.068. Based on the equity, the company is overpriced. -1
  • The TTM is 2.367. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.623MRQ6.068-5.444
MRQ6.068TTM2.367+3.701
TTM2.367YOY2.015+0.352
TTM2.3675Y2.611-0.245
5Y2.61110Y2.474+0.137
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6232.038-1.415
MRQ6.0682.321+3.747
TTM2.3672.444-0.077
YOY2.0153.047-1.032
5Y2.6113.918-1.307
10Y2.4744.245-1.771
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of BIOLASE Inc.

3.1. Institutions holding BIOLASE Inc

Institutions are holding 11.48% of the shares of BIOLASE Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Anson Funds Management LP0.96450.0257185127133846261.0051
2023-12-31BlackRock Inc0.130302501800
2023-12-31Kellett Schaffner Wealth Advisors LLC0.09930.015919060190600
2023-12-31Zhang Financial LLC0.07170.001313770169214.0089
2023-12-31Virtu Financial LLC0.0640.001112289122890
2023-12-31Vanguard Group Inc0.0568010911109110
2023-12-31Two Sigma Investments LLC0.0559010726107260
2023-12-31UBS Group AG0.02930561556150
2023-12-31Tower Research Capital LLC0.01270244783351.6109
2023-12-31Advisor Group Holdings, Inc.0.000305000
2023-12-31Bank of America Corp0.0001023-18-43.9024
2023-12-31Wells Fargo & Co0.000101810125
2023-12-31Morgan Stanley - Brokerage Accounts0.0001014-3-17.6471
2023-12-31Huntington National Bank00100
2023-09-30Perkins Capital Management Inc000-1572-100
2023-09-30Honkamp Krueger Financial Services Inc000-5441-100
2023-12-31Walleye Trading Advisors, LLC000-16934-100
2023-09-30CoreCap Advisors, LLC00000
Total 1.48510.044285069+171014+60.0%

3.2. Funds holding BIOLASE Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.12510.0003240112383613620.5714
2023-12-31BlackRock Extended Equity Market K0.10910.000220948-42-0.2001
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.056801091100
2024-01-31Fidelity Extended Market Index0.02810538700
2023-12-31Extended Equity Market Fund M0.01350.000225901234.9858
2024-01-31Fidelity Series Total Market Index0.01060202619582879.4118
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0012023500
2023-12-31Northern Trust Extended Eq Market Idx0.0012023500
2024-01-31Fidelity Total Market Index0.0006010700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.000305500
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.000204400
2024-01-31Spartan Total Market Index Pool E0.000102400
2024-01-31Spartan Extended Market Index Pool E0.000101500
2023-12-31BlackRock U.S. Equity Market F00700
2023-12-31NT US Market Cap Idx Fd - L00600
2023-12-31Northern Trust Wilshire 5000006-648-99.0826
2023-06-30State St US Ttl Mkt Indx SL Cl I00200
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 500200
2023-12-31SSgA U.S. Extended Market Index Class I00100
Total 0.34690.000766612+25227+37.9%

3.3. Insider Transactions

Insiders are holding 0.468% of the shares of BIOLASE Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-02-11Education Foundation SchulerBUY1307961
2022-12-07Jonathan T Md LordSELL3575
2021-12-15Jonathan T Md LordSELL11038
2021-11-30John R BeaverBUY70045
2021-08-20John R. BeaverBUY35061
2021-05-19John R BeaverBUY40075

4. Summary

4.1. Key Performance Indicators

The key performance indicators of BIOLASE Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.076-0.104+37%-0.214+182%-0.027-64%-0.005-94%
Book Value Per Share--0.3070.342-10%1.059-71%0.641-52%0.890-66%
Current Ratio--1.4041.561-10%3.135-55%2.382-41%2.223-37%
Debt To Asset Ratio--0.8480.835+2%0.596+42%0.756+12%0.618+37%
Debt To Equity Ratio--5.5855.234+7%1.519+268%7.617-27%4.467+25%
Dividend Per Share---0.003-100%0.013-100%0.139-100%0.069-100%
Eps---0.239-0.315+32%-0.316+32%-0.310+30%-0.278+16%
Free Cash Flow Per Share---0.144-0.247+71%-0.363+151%-0.236+64%-0.223+54%
Free Cash Flow To Equity Per Share--0.051-0.032+163%-0.304+692%0.014+274%0.005+1027%
Gross Profit Margin--1.7411.864-7%1.880-7%-9.217+629%-3.570+305%
Intrinsic Value_10Y_max---8.243--------
Intrinsic Value_10Y_min---9.741--------
Intrinsic Value_1Y_max---0.883--------
Intrinsic Value_1Y_min---1.069--------
Intrinsic Value_3Y_max---2.609--------
Intrinsic Value_3Y_min---3.151--------
Intrinsic Value_5Y_max---4.283--------
Intrinsic Value_5Y_min---5.150--------
Market Cap3668164.500-873%35702700.00013733542.625+160%37205668.500-4%19826419.525+80%24657992.975+45%
Net Profit Margin---0.420-0.505+20%-0.513+22%-0.568+35%-0.472+12%
Operating Margin---0.387-0.446+15%-0.455+18%-0.504+30%-0.441+14%
Operating Ratio--1.3391.429-6%1.453-8%1.528-12%1.450-8%
Pb Ratio0.623-873%6.0682.367+156%2.015+201%2.611+132%2.474+145%
Pe Ratio-0.200+90%-1.945-0.652-66%-1.500-23%-1.119-42%-1.441-26%
Price Per Share0.191-873%1.8600.715+160%1.938-4%1.033+80%1.285+45%
Price To Free Cash Flow Ratio-0.331+90%-3.222-1.010-69%-1.302-60%-1.288-60%-3.503+9%
Price To Total Gains Ratio-2.518+90%-24.504-6.485-74%15.541-258%-1.973-92%-1.829-93%
Quick Ratio--0.6170.621-1%1.857-67%1.394-56%1.286-52%
Return On Assets---0.118-0.160+35%-0.124+5%-0.131+11%-0.123+4%
Return On Equity---0.780-1.044+34%-0.327-58%-1.092+40%-0.703-10%
Total Gains Per Share---0.076-0.101+33%-0.202+166%0.112-168%0.065-217%
Usd Book Value--5884000.0006568000.000-10%20320250.000-71%12307200.000-52%17089200.000-66%
Usd Book Value Change Per Share---0.076-0.104+37%-0.214+182%-0.027-64%-0.005-94%
Usd Book Value Per Share--0.3070.342-10%1.059-71%0.641-52%0.890-66%
Usd Dividend Per Share---0.003-100%0.013-100%0.139-100%0.069-100%
Usd Eps---0.239-0.315+32%-0.316+32%-0.310+30%-0.278+16%
Usd Free Cash Flow---2770000.000-4746750.000+71%-6962500.000+151%-4534400.000+64%-4274875.000+54%
Usd Free Cash Flow Per Share---0.144-0.247+71%-0.363+151%-0.236+64%-0.223+54%
Usd Free Cash Flow To Equity Per Share--0.051-0.032+163%-0.304+692%0.014+274%0.005+1027%
Usd Market Cap3668164.500-873%35702700.00013733542.625+160%37205668.500-4%19826419.525+80%24657992.975+45%
Usd Price Per Share0.191-873%1.8600.715+160%1.938-4%1.033+80%1.285+45%
Usd Profit---4589000.000-6291750.000+37%-6013250.000+31%-5084800.000+11%-4748800.000+3%
Usd Revenue--10921000.00012431250.000-12%11704500.000-7%9847400.000+11%11004150.000-1%
Usd Total Gains Per Share---0.076-0.101+33%-0.202+166%0.112-168%0.065-217%
 EOD+3 -5MRQTTM+22 -14YOY+19 -175Y+21 -1510Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of BIOLASE Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.200
Price to Book Ratio (EOD)Between0-10.623
Net Profit Margin (MRQ)Greater than0-0.420
Operating Margin (MRQ)Greater than0-0.387
Quick Ratio (MRQ)Greater than10.617
Current Ratio (MRQ)Greater than11.404
Debt to Asset Ratio (MRQ)Less than10.848
Debt to Equity Ratio (MRQ)Less than15.585
Return on Equity (MRQ)Greater than0.15-0.780
Return on Assets (MRQ)Greater than0.05-0.118
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of BIOLASE Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.006
Ma 20Greater thanMa 500.147
Ma 50Greater thanMa 1000.374
Ma 100Greater thanMa 2000.796
OpenGreater thanClose0.160
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets38,745
Total Liabilities32,861
Total Stockholder Equity5,884
 As reported
Total Liabilities 32,861
Total Stockholder Equity+ 5,884
Total Assets = 38,745

Assets

Total Assets38,745
Total Current Assets27,782
Long-term Assets10,963
Total Current Assets
Cash And Cash Equivalents 7,809
Net Receivables 4,388
Inventory 13,824
Other Current Assets 1,761
Total Current Assets  (as reported)27,782
Total Current Assets  (calculated)27,782
+/-0
Long-term Assets
Property Plant Equipment 7,767
Goodwill 2,926
Long-term Assets Other 270
Long-term Assets  (as reported)10,963
Long-term Assets  (calculated)10,963
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities19,782
Long-term Liabilities13,079
Total Stockholder Equity5,884
Total Current Liabilities
Short-term Debt 2,800
Short Long Term Debt 2,800
Accounts payable 7,178
Other Current Liabilities 7,613
Total Current Liabilities  (as reported)19,782
Total Current Liabilities  (calculated)20,391
+/- 609
Long-term Liabilities
Long term Debt 11,307
Capital Lease Obligations 995
Long-term Liabilities Other 78
Long-term Liabilities  (as reported)13,079
Long-term Liabilities  (calculated)12,380
+/- 699
Total Stockholder Equity
Common Stock2
Retained Earnings -311,474
Other Stockholders Equity 312,523
Total Stockholder Equity (as reported)5,884
Total Stockholder Equity (calculated)1,051
+/- 4,833
Other
Capital Stock5,554
Cash and Short Term Investments 7,809
Common Stock Shares Outstanding 1,179
Current Deferred Revenue2,191
Liabilities and Stockholders Equity 38,745
Net Debt 7,293
Net Invested Capital 14,439
Net Working Capital 8,000
Property Plant and Equipment Gross 7,767
Short Long Term Debt Total 15,102



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-31
> Total Assets 
0
5,300
5,600
5,600
4,700
4,400
4,200
5,100
0
3,000
4,100
2,400
1,700
2,100
3,000
2,500
2,000
1,500
1,000
4,700
4,700
4,000
3,700
3,400
3,300
5,800
4,600
3,900
3,900
4,800
3,900
2,672
2,672
6,278
6,599
6,599
6,599
5,733
6,236
7,561
7,561
9,981
11,420
14,395
15,919
25,605
26,315
44,501
82,374
85,426
72,549
58,746
53,822
58,746
43,764
45,129
44,026
42,748
42,888
48,578
44,804
42,765
40,043
44,308
41,692
38,615
40,943
35,708
21,888
22,415
23,254
22,177
19,604
20,279
19,493
18,147
20,305
29,917
29,390
29,807
27,893
28,213
28,764
31,973
30,524
32,463
32,859
31,038
28,657
26,398
29,902
59,403
54,694
51,343
47,149
42,251
38,419
36,001
44,619
41,941
37,040
42,283
37,351
42,984
40,384
35,649
34,255
38,516
33,810
32,362
28,273
31,847
24,531
27,756
41,996
41,025
63,484
61,249
58,514
55,284
50,242
50,854
42,865
38,186
41,944
39,633
38,745
38,74539,63341,94438,18642,86550,85450,24255,28458,51461,24963,48441,02541,99627,75624,53131,84728,27332,36233,81038,51634,25535,64940,38442,98437,35142,28337,04041,94144,61936,00138,41942,25147,14951,34354,69459,40329,90226,39828,65731,03832,85932,46330,52431,97328,76428,21327,89329,80729,39029,91720,30518,14719,49320,27919,60422,17723,25422,41521,88835,70840,94338,61541,69244,30840,04342,76544,80448,57842,88842,74844,02645,12943,76458,74653,82258,74672,54985,42682,37444,50126,31525,60515,91914,39511,4209,9817,5617,5616,2365,7336,5996,5996,5996,2782,6722,6723,9004,8003,9003,9004,6005,8003,3003,4003,7004,0004,7004,7001,0001,5002,0002,5003,0002,1001,7002,4004,1003,00005,1004,2004,4004,7005,6005,6005,3000
   > Total Current Assets 
0
4,400
4,200
3,700
2,000
2,000
2,000
2,900
0
1,300
2,500
1,900
1,200
1,700
2,700
2,200
1,700
1,300
700
4,400
4,400
3,600
3,300
3,000
2,900
5,300
3,900
3,300
3,300
4,300
3,300
2,280
2,280
5,688
4,095
4,162
4,162
5,301
5,765
6,912
6,912
8,028
9,564
12,550
14,069
17,917
18,440
23,296
62,518
31,356
52,179
51,095
35,760
51,095
35,435
36,455
34,451
32,744
32,811
38,989
35,437
33,744
31,233
35,776
33,388
30,489
33,045
28,794
15,414
15,999
17,258
16,412
14,115
15,566
14,998
13,943
15,704
25,332
24,853
25,326
23,255
23,427
23,859
26,917
25,431
27,478
27,760
25,854
23,570
21,439
25,110
54,798
48,967
45,211
40,282
34,800
31,109
28,507
37,277
33,987
29,316
34,450
29,740
36,050
33,584
29,155
28,033
33,307
28,849
27,058
23,289
27,019
19,969
22,894
36,047
35,110
57,749
55,340
52,654
49,354
43,783
44,267
33,881
28,959
31,964
28,147
27,782
27,78228,14731,96428,95933,88144,26743,78349,35452,65455,34057,74935,11036,04722,89419,96927,01923,28927,05828,84933,30728,03329,15533,58436,05029,74034,45029,31633,98737,27728,50731,10934,80040,28245,21148,96754,79825,11021,43923,57025,85427,76027,47825,43126,91723,85923,42723,25525,32624,85325,33215,70413,94314,99815,56614,11516,41217,25815,99915,41428,79433,04530,48933,38835,77631,23333,74435,43738,98932,81132,74434,45136,45535,43551,09535,76051,09552,17931,35662,51823,29618,44017,91714,06912,5509,5648,0286,9126,9125,7655,3014,1624,1624,0955,6882,2802,2803,3004,3003,3003,3003,9005,3002,9003,0003,3003,6004,4004,4007001,3001,7002,2002,7001,7001,2001,9002,5001,30002,9002,0002,0002,0003,7004,2004,4000
       Cash And Cash Equivalents 
0
1,300
300
1,300
100
0
0
2,000
0
500
1,700
1,200
400
1,100
1,800
1,600
1,100
600
100
300
300
300
300
200
100
800
200
400
400
1,800
1,400
1,181
1,181
3,422
1,316
2,002
2,002
3,507
2,400
2,670
2,670
2,568
2,920
3,940
5,811
6,646
6,123
11,111
50,095
5,374
3,993
6,140
2,946
6,140
7,884
8,272
5,974
7,721
5,746
14,676
12,789
11,972
11,890
14,566
13,881
14,507
15,485
11,235
1,810
3,487
3,879
2,975
3,428
2,895
2,226
1,694
1,632
10,134
5,757
3,307
2,772
1,607
1,295
2,543
1,229
2,101
4,151
1,440
1,835
2,083
2,759
31,560
23,739
19,922
15,194
11,699
6,627
4,877
12,650
8,924
3,576
7,916
4,454
11,645
8,479
2,895
2,238
8,044
2,956
3,720
2,091
5,789
1,511
5,437
18,847
17,564
40,842
37,081
33,385
29,972
21,606
19,549
9,960
4,181
6,532
6,930
7,809
7,8096,9306,5324,1819,96019,54921,60629,97233,38537,08140,84217,56418,8475,4371,5115,7892,0913,7202,9568,0442,2382,8958,47911,6454,4547,9163,5768,92412,6504,8776,62711,69915,19419,92223,73931,5602,7592,0831,8351,4404,1512,1011,2292,5431,2951,6072,7723,3075,75710,1341,6321,6942,2262,8953,4282,9753,8793,4871,81011,23515,48514,50713,88114,56611,89011,97212,78914,6765,7467,7215,9748,2727,8846,1402,9466,1403,9935,37450,09511,1116,1236,6465,8113,9402,9202,5682,6702,6702,4003,5072,0022,0021,3163,4221,1811,1811,4001,8004004002008001002003003003003001006001,1001,6001,8001,1004001,2001,70050002,000001001,3003001,3000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,942
32,175
25,326
9,903
25,326
9,934
9,863
9,861
9,881
9,949
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106
0
0
0
0
0
0
0
0
0
0
200
200
200
200
200
200
251
251
251
251
251
251
251
251
202
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000202251251251251251251251251200200200200200200000000000010600000000000000000000009,9499,8819,8619,8639,93425,3269,90325,32632,1759,9420000000000000000000000000000000000000000000000000
       Net Receivables 
0
1,100
1,500
1,200
500
600
600
200
0
400
100
100
0
100
300
100
0
0
0
100
100
400
600
1,100
1,100
300
100
600
600
800
800
331
331
1,191
1,249
758
758
332
1,258
2,095
2,095
2,722
3,478
4,790
3,706
5,367
7,402
5,771
6,205
8,794
6,305
9,635
12,551
9,635
6,277
8,404
9,953
7,558
10,149
15,193
12,286
11,647
7,497
11,266
10,192
5,354
4,792
3,758
1,728
2,538
3,275
4,229
1,022
1,675
2,861
3,331
5,966
6,398
8,074
8,899
8,983
9,576
10,309
11,680
10,644
11,477
10,802
11,127
8,556
6,597
9,264
9,004
9,811
9,778
9,243
8,948
10,106
11,036
9,938
9,784
9,220
9,804
9,708
10,124
9,739
10,399
11,399
11,112
11,743
9,740
8,474
8,760
4,749
4,119
3,393
3,059
3,266
3,819
3,637
4,238
5,180
6,081
4,846
5,841
5,158
5,717
4,388
4,3885,7175,1585,8414,8466,0815,1804,2383,6373,8193,2663,0593,3934,1194,7498,7608,4749,74011,74311,11211,39910,3999,73910,1249,7089,8049,2209,7849,93811,03610,1068,9489,2439,7789,8119,0049,2646,5978,55611,12710,80211,47710,64411,68010,3099,5768,9838,8998,0746,3985,9663,3312,8611,6751,0224,2293,2752,5381,7283,7584,7925,35410,19211,2667,49711,64712,28615,19310,1497,5589,9538,4046,2779,63512,5519,6356,3058,7946,2055,7717,4025,3673,7064,7903,4782,7222,0952,0951,2583327587581,2491,1913313318008006006001003001,1001,100600400100100000100300100010010040002006006005001,2001,5001,1000
       Other Current Assets 
0
300
300
100
200
200
300
100
0
100
200
0
200
0
300
100
100
200
200
3,600
3,600
2,400
1,900
700
300
2,500
1,500
400
400
100
100
110
110
136
177
180
180
198
276
260
260
541
822
1,028
862
1,437
460
55
2,196
2,168
2,574
1,814
1,524
1,814
813
1,293
1,015
1,208
900
1,346
1,483
1,313
1,072
2,317
1,701
1,288
912
1,391
1,383
968
1,016
1,347
1,255
531
592
576
928
771
1,199
1,808
1,163
1,544
1,055
1,552
1,637
1,341
1,062
1,909
1,288
909
1,288
1,726
2,045
1,631
1,526
1,387
1,609
1,132
895
1,505
1,576
1,287
1,225
1,732
1,714
1,602
771
1,591
1,815
952
875
1,163
1,205
1,094
903
3,018
1,560
1,521
1,366
2,012
2,183
2,064
2,648
3,053
2,499
2,170
1,761
1,7612,1702,4993,0532,6482,0642,1832,0121,3661,5211,5603,0189031,0941,2051,1638759521,8151,5917711,6021,7141,7321,2251,2871,5761,5058951,1321,6091,3871,5261,6312,0451,7261,2889091,2881,9091,0621,3411,6371,5521,0551,5441,1631,8081,1997719285765925311,2551,3471,0169681,3831,3919121,2881,7012,3171,0721,3131,4831,3469001,2081,0151,2938131,8141,5241,8142,5742,1682,196554601,4378621,0288225412602602761981801801771361101101001004004001,5002,5003007001,9002,4003,6003,6002002001001003000200020010001003002002001003003000
   > Long-term Assets 
0
900
1,400
1,900
2,700
2,400
2,200
2,200
0
1,700
1,600
500
500
400
300
300
300
200
300
300
300
400
400
400
400
500
700
600
600
500
600
392
392
589
2,505
2,437
2,437
432
471
649
649
1,953
1,856
1,845
1,850
7,688
7,875
21,205
19,856
54,070
20,370
7,651
18,062
7,651
8,329
8,674
9,575
10,004
10,077
9,589
9,367
9,021
8,810
8,532
8,304
8,126
7,898
6,914
6,474
6,416
5,996
5,765
5,489
4,713
4,495
4,204
4,601
4,585
4,537
4,481
4,638
4,786
4,905
5,056
5,093
4,985
5,099
5,184
5,087
4,959
4,792
4,605
5,727
6,132
6,867
7,451
7,310
7,494
7,342
7,954
7,724
7,833
7,611
6,934
6,800
6,494
6,222
5,209
4,961
5,304
4,984
4,828
4,562
4,862
5,949
5,915
5,735
5,909
5,860
5,930
6,459
6,587
8,984
9,227
9,980
11,486
10,963
10,96311,4869,9809,2278,9846,5876,4595,9305,8605,9095,7355,9155,9494,8624,5624,8284,9845,3044,9615,2096,2226,4946,8006,9347,6117,8337,7247,9547,3427,4947,3107,4516,8676,1325,7274,6054,7924,9595,0875,1845,0994,9855,0935,0564,9054,7864,6384,4814,5374,5854,6014,2044,4954,7135,4895,7655,9966,4166,4746,9147,8988,1268,3048,5328,8109,0219,3679,58910,07710,0049,5758,6748,3297,65118,0627,65120,37054,07019,85621,2057,8757,6881,8501,8451,8561,9536496494714322,4372,4372,5055893923926005006006007005004004004004003003003002003003003004005005001,6001,70002,2002,2002,4002,7001,9001,4009000
       Property Plant Equipment 
0
700
700
1,100
1,300
1,100
1,000
900
0
600
500
400
400
300
300
300
300
200
200
200
200
200
200
200
200
200
200
400
400
400
400
204
204
423
2,382
2,329
2,329
336
371
392
392
1,609
1,597
1,733
1,750
1,861
1,753
1,973
1,988
2,046
2,169
3,025
3,035
3,025
3,370
3,827
4,572
5,335
5,276
4,851
4,717
4,458
4,354
4,040
3,897
3,805
3,667
3,040
2,659
2,621
2,361
2,180
1,938
1,185
996
755
1,184
1,184
1,168
1,148
1,338
1,325
1,501
1,509
1,616
1,581
1,711
1,826
1,749
1,625
1,467
1,295
1,747
2,366
3,118
3,727
3,791
3,994
3,856
4,478
4,465
4,572
4,350
3,674
3,424
3,164
2,927
1,975
1,733
1,585
1,340
1,469
1,152
1,430
2,803
2,758
2,583
2,758
2,712
2,784
3,302
3,420
5,824
6,046
6,797
8,281
7,767
7,7678,2816,7976,0465,8243,4203,3022,7842,7122,7582,5832,7582,8031,4301,1521,4691,3401,5851,7331,9752,9273,1643,4243,6744,3504,5724,4654,4783,8563,9943,7913,7273,1182,3661,7471,2951,4671,6251,7491,8261,7111,5811,6161,5091,5011,3251,3381,1481,1681,1841,1847559961,1851,9382,1802,3612,6212,6593,0403,6673,8053,8974,0404,3544,4584,7174,8515,2765,3354,5723,8273,3703,0253,0353,0252,1692,0461,9881,9731,7531,8611,7501,7331,5971,6093923923713362,3292,3292,38242320420440040040040020020020020020020020020020020030030030030040040050060009001,0001,1001,3001,1007007000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,845
2,926
2,926,000
2,926
2,926
2,926
2,926
2,926
2,926,000
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,926,0002,9262,9262,9262,9262,9262,926,0002,9262,845000000000000000000000000000000000000000000000
       Intangible Assets 
0
100
500
600
1,200
1,100
1,100
1,100
0
1,000
1,000
0
0
0
0
0
0
0
0
0
100
100
100
100
100
200
100
100
100
100
100
127
127
116
110
104
104
93
97
91
91
79
73
67
61
5,549
5,571
5,513
5,520
5,458
5,395
4,588
5,036
4,588
4,850
4,757
1,738
1,648
1,558
1,469
1,379
1,290
1,200
1,208
1,116
1,023
930
613
570
537
505
472
439
407
374
342
309
277
244
212
179
147
114
300
254
217
200
183
165
148
131
114
96
79
65
51
37
23
9
2,926
2,926
2,926
2,926
2,926
2,926
2,926
2,926
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000002,9262,9262,9262,9262,9262,9262,9262,92692337516579961141311481651832002172543001141471792122442773093423744074394725055375706139301,0231,1161,2081,2001,2901,3791,4691,5581,6481,7384,7574,8504,5885,0364,5885,3955,4585,5205,5135,5715,54961677379919197931041041101161271271001001001001002001001001001001000000000001,0001,00001,1001,1001,1001,2006005001000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
183
166
122
108
102
96
100
257
332
344
259
112
100
5,827
6,122
19,232
19,100
53,318
19,669
4,626
15,027
5,023
4,959
4,847
5,003
4,669
4,801
4,738
4,650
4,563
4,456
4,492
4,407
4,321
4,231
3,874
3,815
3,795
3,635
3,585
3,551
3,528
3,499
3,449
3,417
3,401
3,369
3,333
3,300
3,461
3,404
3,547
3,477
3,404
3,388
3,358
3,338
3,334
3,325
3,310
3,980
3,766
3,749
3,724
3,519
3,500
3,486
3,476
3,259
3,261
3,261
3,260
450
404
369
308
-398
293
318
433
484
506
2,281
2,207
226
225
222
220
231
241
234
255
0
279
0
027902552342412312202222252262,2072,281506484433318293-3983083694044503,2603,2613,2613,2593,4763,4863,5003,5193,7243,7493,7663,9803,3103,3253,3343,3383,3583,3883,4043,4773,5473,4043,4613,3003,3333,3693,4013,4173,4493,4993,5283,5513,5853,6353,7953,8153,8744,2314,3214,4074,4924,4564,5634,6504,7384,8014,6695,0034,8474,9595,02315,0274,62619,66953,31819,10019,2326,1225,8271001122593443322571009610210812216618300000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
8
8
8
8
16
15
16
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000161615168888131300000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
2,900
3,100
2,800
2,800
3,100
2,300
2,400
0
800
900
700
800
600
600
700
600
600
700
800
800
700
900
1,300
2,000
2,100
2,400
3,200
3,200
3,000
2,900
3,612
3,612
3,588
5,045
5,542
5,542
4,902
5,291
5,982
5,982
6,878
7,546
9,208
8,444
13,159
11,186
12,719
7,607
9,824
11,467
24,768
20,508
24,768
21,484
23,835
24,216
24,772
23,607
26,612
24,037
21,950
21,900
27,817
24,348
19,996
26,463
26,318
17,024
14,676
14,115
14,248
16,879
21,582
23,040
21,194
15,968
15,006
15,106
17,238
15,986
17,612
18,449
20,179
20,847
24,297
23,358
22,557
19,652
23,495
18,803
17,347
17,566
20,288
20,805
17,326
16,826
17,049
18,559
19,876
18,674
16,979
16,186
13,724
15,447
15,259
17,919
27,427
26,837
28,570
29,339
31,470
29,387
26,447
28,145
30,997
29,968
27,993
28,192
30,076
29,642
29,239
29,007
33,297
33,786
32,292
32,861
32,86132,29233,78633,29729,00729,23929,64230,07628,19227,99329,96830,99728,14526,44729,38731,47029,33928,57026,83727,42717,91915,25915,44713,72416,18616,97918,67419,87618,55917,04916,82617,32620,80520,28817,56617,34718,80323,49519,65222,55723,35824,29720,84720,17918,44917,61215,98617,23815,10615,00615,96821,19423,04021,58216,87914,24814,11514,67617,02426,31826,46319,99624,34827,81721,90021,95024,03726,61223,60724,77224,21623,83521,48424,76820,50824,76811,4679,8247,60712,71911,18613,1598,4449,2087,5466,8785,9825,9825,2914,9025,5425,5425,0453,5883,6123,6122,9003,0003,2003,2002,4002,1002,0001,30090070080080070060060070060060080070090080002,4002,3003,1002,8002,8003,1002,9000
   > Total Current Liabilities 
0
2,500
2,800
2,600
2,000
2,200
1,500
1,800
0
800
800
700
700
600
600
700
600
700
700
800
800
700
900
1,300
2,000
2,100
2,300
3,200
3,200
3,100
2,900
3,612
3,612
3,588
3,865
4,368
4,368
4,650
5,070
5,777
5,777
5,896
6,588
9,066
8,318
13,048
11,091
12,640
7,544
9,777
11,435
21,145
20,282
21,145
21,262
23,633
23,979
24,533
20,178
22,063
19,368
17,689
18,249
24,783
21,538
17,485
24,049
23,771
14,487
12,020
11,485
11,610
14,301
18,058
19,492
19,660
14,191
13,575
13,703
16,282
15,218
16,832
17,655
19,375
20,257
23,672
22,722
21,939
19,020
22,601
17,774
16,151
15,763
17,908
18,300
15,106
14,546
14,951
16,449
18,014
17,106
15,614
15,025
13,370
13,132
14,734
17,252
15,967
15,120
13,290
14,066
25,779
23,679
21,089
21,433
11,223
11,270
12,719
13,457
13,844
13,112
13,951
13,763
17,807
18,999
18,384
19,782
19,78218,38418,99917,80713,76313,95113,11213,84413,45712,71911,27011,22321,43321,08923,67925,77914,06613,29015,12015,96717,25214,73413,13213,37015,02515,61417,10618,01416,44914,95114,54615,10618,30017,90815,76316,15117,77422,60119,02021,93922,72223,67220,25719,37517,65516,83215,21816,28213,70313,57514,19119,66019,49218,05814,30111,61011,48512,02014,48723,77124,04917,48521,53824,78318,24917,68919,36822,06320,17824,53323,97923,63321,26221,14520,28221,14511,4359,7777,54412,64011,09113,0488,3189,0666,5885,8965,7775,7775,0704,6504,3684,3683,8653,5883,6123,6122,9003,1003,2003,2002,3002,1002,0001,30090070080080070070060070060060070070080080001,8001,5002,2002,0002,6002,8002,5000
       Short-term Debt 
0
400
400
300
300
600
400
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
1,300
1,200
1,400
1,700
1,700
1,300
1,300
1,342
1,342
1,770
1,812
1,812
1,812
1,792
1,792
1,792
1,792
2,138
2,135
3,012
3,049
3,124
3,000
2,680
4,967
5,356
5,104
0
1,850
11,467
5,000
5,000
5,000
5,000
0
0
0
0
0
3,552
1,972
0
4,410
5,404
0
0
0
0
5,154
644
1,138
2,622
5,035
0
0
0
0
1,935
2,189
1,637
3,261
5,992
5,534
4,633
2,878
3,304
0
0
143
157
142
167
168
169
169
159
117
74
32
0
1,934
80
1,500
21
718
565
476
13,466
13,702
13,544
13,160
305
340
1,078
1,804
405
532
591
615
700
2,171
2,961
2,800
2,8002,9612,1717006155915324051,8041,07834030513,16013,54413,70213,466476565718211,500801,93403274117159169169168167142157143003,3042,8784,6335,5345,9923,2611,6372,1891,93500005,0352,6221,1386445,15400005,4044,41001,9723,552000005,0005,0005,0005,00011,4671,85005,1045,3564,9672,6803,0003,1243,0493,0122,1352,1381,7921,7921,7921,7921,8121,8121,8121,7701,3421,3421,3001,3001,7001,7001,4001,2001,3003000000000000000005004006003003004004000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326
0
0
0
159
117
74
32
0
1,934
80
0
0
718
0
0
13,466
13,562
13,544
12,946
0
0
700
1,400
0
0
0
0
700
1,400
2,100
2,800
2,8002,1001,40070000001,4007000012,94613,54413,56213,4660071800801,9340327411715900032600000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
1,100
1,700
1,200
1,100
1,200
600
300
0
0
0
100
100
0
0
0
0
100
100
100
100
100
300
500
200
200
400
800
800
700
500
792
792
625
837
946
946
1,002
1,236
1,656
1,656
1,422
1,338
2,082
1,669
1,879
2,445
3,590
2,024
3,637
4,449
7,147
7,679
7,147
6,902
5,000
9,698
6,735
6,291
7,699
7,306
5,557
6,807
6,151
7,934
7,208
8,302
7,509
4,265
4,609
5,284
4,887
4,025
4,491
4,223
4,029
4,540
5,035
5,859
7,804
7,524
6,859
7,183
7,663
8,708
9,299
9,346
8,560
7,776
10,016
9,535
8,357
7,645
8,849
9,309
5,960
6,971
6,914
7,875
9,125
9,183
8,166
7,679
5,109
5,785
6,932
7,570
5,953
5,894
5,878
6,604
5,332
4,056
2,510
2,592
2,651
3,072
3,502
3,597
3,309
4,643
4,961
4,974
5,786
7,540
6,314
7,178
7,1786,3147,5405,7864,9744,9614,6433,3093,5973,5023,0722,6512,5922,5104,0565,3326,6045,8785,8945,9537,5706,9325,7855,1097,6798,1669,1839,1257,8756,9146,9715,9609,3098,8497,6458,3579,53510,0167,7768,5609,3469,2998,7087,6637,1836,8597,5247,8045,8595,0354,5404,0294,2234,4914,0254,8875,2844,6094,2657,5098,3027,2087,9346,1516,8075,5577,3067,6996,2916,7359,6985,0006,9027,1477,6797,1474,4493,6372,0243,5902,4451,8791,6692,0821,3381,4221,6561,6561,2361,00294694683762579279250070080080040020020050030010010010010010000001001000003006001,2001,1001,2001,7001,1000
       Other Current Liabilities 
0
1,000
700
1,100
600
400
500
1,000
0
800
800
600
600
600
600
700
600
600
600
700
700
600
600
500
500
700
500
700
700
1,100
1,100
1,478
1,478
1,193
1,216
1,610
1,609
288
288
2,329
353
2,048
2,854
-325,028
3,306
4,313
4,643
6,226
63
63
63
11,530
8,218
63
7,096
11,387
7,292
7,400
6,851
8,933
6,785
6,514
5,920
9,431
6,771
6,209
7,759
8,255
7,958
5,823
5,057
5,600
3,982
10,947
12,751
11,359
2,954
5,437
5,759
6,177
5,442
5,201
5,041
6,267
4,879
5,084
4,484
4,997
4,941
5,907
5,697
5,188
5,001
5,756
5,760
5,739
4,361
4,641
5,285
5,619
5,046
4,586
4,681
5,609
5,119
5,575
5,866
7,517
5,995
4,334
4,474
4,744
3,939
3,549
4,065
6,362
5,897
6,083
5,778
7,871
5,495
5,907
6,304
9,210
7,206
6,873
7,613
7,6136,8737,2069,2106,3045,9075,4957,8715,7786,0835,8976,3624,0653,5493,9394,7444,4744,3345,9957,5175,8665,5755,1195,6094,6814,5865,0465,6195,2854,6414,3615,7395,7605,7565,0015,1885,6975,9074,9414,9974,4845,0844,8796,2675,0415,2015,4426,1775,7595,4372,95411,35912,75110,9473,9825,6005,0575,8237,9588,2557,7596,2096,7719,4315,9206,5146,7858,9336,8517,4007,29211,3877,096638,21811,5306363636,2264,6434,3133,306-325,0282,8542,0483532,3292882881,6091,6101,2161,1931,4781,4781,1001,10070070050070050050060060070070060060060070060060060060080080001,0005004006001,1007001,0000
   > Long-term Liabilities 
0
400
300
200
800
900
800
600
0
0
100
100
100
0
0
0
0
-100
100
0
100
100
300
800
1,500
1,400
100
0
2,500
-100
1,800
0
2,134
2,395
1,180
1,175
1,175
253
221
205
205
982
958
142
126
111
95
79
63
47
32
3,623
226
3,623
222
202
237
239
3,429
4,549
4,669
4,261
3,651
3,034
2,810
2,511
2,414
2,547
2,537
2,656
2,630
2,638
2,578
3,524
3,548
1,534
1,777
1,431
1,403
956
768
780
794
804
590
625
636
618
632
894
1,029
1,196
1,803
2,380
2,505
2,220
2,280
2,098
2,110
1,862
1,568
1,365
1,161
354
2,315
525
667
11,460
11,717
15,280
15,273
5,691
5,708
5,358
6,712
19,774
18,698
15,274
14,735
16,232
16,530
15,288
15,244
15,490
14,787
13,908
13,079
13,07913,90814,78715,49015,24415,28816,53016,23214,73515,27418,69819,7746,7125,3585,7085,69115,27315,28011,71711,4606675252,3153541,1611,3651,5681,8622,1102,0982,2802,2202,5052,3801,8031,1961,0298946326186366255908047947807689561,4031,4311,7771,5343,5483,5242,5782,6382,6302,6562,5372,5472,4142,5112,8103,0343,6514,2614,6694,5493,4292392372022223,6232263,62332476379951111261429589822052052212531,1751,1751,1802,3952,13401,800-1002,50001001,4001,5008003001001000100-1000000100100100006008009008002003004000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
240
238
201
159
117
74
32
0
0
0
0
0
1,934
80
50
10,836
10,906
13,328
13,356
0
0
3,140
3,140
16,186
16,295
12,703
0
0
13,666
0
0
0
0
0
0
00000013,6660012,70316,29516,1863,1403,1400013,35613,32810,90610,83650801,93400000327411715920123824000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
8
8
8
8
16
15
16
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000161615168888131300000000000000000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,965
3,965
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000003,9653,965000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
253
252
221
205
189
174
158
142
126
111
95
79
63
47
32
3,462
0
0
0
0
0
0
3,194
4,278
4,379
3,953
3,324
2,692
2,449
2,132
2,017
2,171
2,144
2,247
2,204
2,165
2,087
757
1,256
990
1,215
851
805
362
156
150
147
141
34
34
34
1
0
247
367
519
871
1,434
1,581
1,323
1,410
1,256
1,295
1,064
755
537
318
250
381
445
617
624
705
1,874
1,902
1,723
1,743
1,866
1,713
1,814
717
969
1,064
1,180
1,202
966
1,023
0
0
787
0
0787001,0239661,2021,1801,0649697171,8141,7131,8661,7431,7231,9021,8747056246174453812503185377551,0641,2951,2561,4101,3231,5811,434871519367247013434341411471501563628058511,2159901,2567572,0872,1652,2042,2472,1442,1712,0172,1322,4492,6923,3243,9534,3794,2783,1940000003,4623247637995111126142158174189205221252253000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
621
631
619
629
641
652
666
556
591
602
618
632
647
662
677
923
909
894
880
865
850
835
821
833
845
857
115
114
112
105
77
72
72
71
436
390
412
412
374
343
333
0
0
303
0
0
0
0
0
0
000000303003333433744124123904367172727710511211411585784583382183585086588089490992367766264763261860259155666665264162961963162100000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
2,400
2,500
2,800
1,900
1,300
1,900
2,700
0
2,200
3,200
1,700
900
1,500
2,400
1,800
1,400
900
300
3,900
3,900
3,300
2,800
2,100
1,300
3,700
2,200
700
700
1,800
1,000
-939
-939
2,690
1,554
1,057
1,057
831
945
1,579
1,579
3,103
3,874
5,187
7,475
12,446
15,129
31,782
74,767
75,602
61,082
33,978
33,314
33,978
22,280
21,294
19,810
17,976
19,281
21,966
20,767
20,815
18,143
16,491
17,344
18,619
14,480
9,390
4,864
7,739
9,139
7,929
2,725
-1,303
-3,547
-3,047
4,337
14,911
14,284
12,569
11,907
10,601
10,315
11,794
9,677
8,166
9,501
8,481
9,005
2,903
11,099
42,056
37,128
31,055
26,344
24,925
21,593
18,952
26,060
22,065
18,366
25,304
21,165
29,260
24,937
20,390
16,336
11,089
6,973
3,792
-1,066
377
-4,856
1,309
13,851
10,028
33,516
33,256
30,322
25,208
20,600
21,615
13,858
4,889
8,158
7,341
5,884
5,8847,3418,1584,88913,85821,61520,60025,20830,32233,25633,51610,02813,8511,309-4,856377-1,0663,7926,97311,08916,33620,39024,93729,26021,16525,30418,36622,06526,06018,95221,59324,92526,34431,05537,12842,05611,0992,9039,0058,4819,5018,1669,67711,79410,31510,60111,90712,56914,28414,9114,337-3,047-3,547-1,3032,7257,9299,1397,7394,8649,39014,48018,61917,34416,49118,14320,81520,76721,96619,28117,97619,81021,29422,28033,97833,31433,97861,08275,60274,76731,78215,12912,4467,4755,1873,8743,1031,5791,5799458311,0571,0571,5542,690-939-9391,0001,8007007002,2003,7001,3002,1002,8003,3003,9003,9003009001,4001,8002,4001,5009001,7003,2002,20002,7001,9001,3001,9002,8002,5002,4000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
18
20
19
19
19
20
20
20
20
20
20
20
21
22
22
22
24
24
24
25
25
25
25
26
26
26
26
26
26
26
26
26
27
27
27
27
27
27
27
27
27
27
27
27
30
32
33
33
33
33
33
34
34
34
37
38
40
40
44
58
58
58
58
58
58
58
68
68
68
76
76
102
102
20
20
21
21
22
22
31
32
50
93
98
149
151
153
154
155
7
7
8
26
1
2
212687715515415315114998935032312222212120201021027676686868585858585858584440403837343434333333333332302727272727272727272727272626262626262626262525252524242422222221202020202020201919192018180000000000000000000000000000000
   Retained Earnings Total Equity000000-272,31000-258,979-258,277-251,376-245,234-245,251-240,553-234,547-230,960-225,491-221,592-216,692-209,773-205,109-200,197-195,176-191,334-186,723-182,433-178,325-173,898-170,752-167,219-162,954-160,496-155,153-148,112-142,676-138,571-135,076-128,637-123,750-121,516-117,467-114,899-112,268-113,309-112,761-110,884-109,212-107,182-106,22900000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-500
-500
-600
-700
-600
-700
-800
0
-900
-900
-800
-800
-800
-900
-900
-900
-1,000
-1,000
-1,000
-1,000
-1,100
-1,100
-1,100
-1,200
-1,200
-1,200
-1,200
-1,200
-1,300
-1,300
-1,301
-1,301
-1,346
-1,218
-249
-249
-252
-281
-312
-312
-16
-27
-57
-83
-134
-130
-147
-159
-290
-177
-225
-534
-225
-341
-322
-356
-449
-269
108
230
589
1,146
54
111
114
34
-187
-505
-278
-194
-222
-335
-516
-289
-324
-210
-163
-283
-360
-297
-412
-374
-320
-376
-385
-297
-274
-273
-282
-455
-557
-790
-757
-747
-801
-702
-756
-732
-876
-846
-689
-599
-576
-492
-610
-607
-670
-725
-711
-840
-701
-719
-645
-534
-385
-533
-468
-558
-623
-664
-886
-1,038
-733
-653
-614
-719
-719-614-653-733-1,038-886-664-623-558-468-533-385-534-645-719-701-840-711-725-670-607-610-492-576-599-689-846-876-732-756-702-801-747-757-790-557-455-282-273-274-297-385-376-320-374-412-297-360-283-163-210-324-289-516-335-222-194-278-505-18734114111541,146589230108-269-449-356-322-341-225-534-225-177-290-159-147-130-134-83-57-27-16-312-312-281-252-249-249-1,218-1,346-1,301-1,301-1,300-1,300-1,200-1,200-1,200-1,200-1,200-1,100-1,100-1,100-1,000-1,000-1,000-1,000-900-900-900-800-800-800-900-9000-800-700-600-700-600-500-5000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137,670
138,115
138,507
139,454
140,140
140,364
140,747
141,317
142,383
147,676
148,866
154,274
154,620
150,081
185,231
185,972
186,907
187,529
188,622
189,456
190,402
200,622
201,198
201,577
212,640
213,022
224,910
225,524
226,089
226,696
228,430
229,269
229,972
230,712
235,594
236,384
247,155
259,385
261,573
292,141
292,517
0
0
293,419
0
0
0
0
0
0
000000293,41900292,517292,141261,573259,385247,155236,384235,594230,712229,972229,269228,430226,696226,089225,524224,910213,022212,640201,577201,198200,622190,402189,456188,622187,529186,907185,972185,231150,081154,620154,274148,866147,676142,383141,317140,747140,364140,140139,454138,507138,115137,67000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-16,399-13,43500000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
9,400
10,500
13,100
13,900
15,100
17,400
20,800
0
21,000
22,800
22,800
22,800
23,800
25,000
25,000
25,100
25,300
25,300
29,700
29,700
30,600
30,700
30,800
31,000
34,600
39,700
39,900
39,900
43,000
43,100
43,111
43,111
48,702
48,604
0
47,781
48,477
48,519
0
48,774
49,604
49,652
49,497
51,136
56,704
56,816
59,188
101,511
101,761
88,361
85,163
89,082
85,163
89,865
90,085
90,919
91,614
93,746
95,016
95,574
96,164
96,443
97,031
97,801
98,450
98,882
99,299
99,767
100,085
100,542
100,829
101,043
101,360
101,615
101,976
109,993
121,271
121,716
122,108
123,055
123,741
123,965
124,348
124,918
125,984
131,277
132,467
137,875
138,221
150,081
185,231
185,972
186,907
187,529
188,622
189,456
190,402
200,622
201,198
201,577
212,640
213,022
224,910
225,524
226,089
226,696
228,430
229,269
229,972
230,712
235,594
232,419
219,399
259,385
261,573
292,141
292,517
292,948
293,177
243,177
249,560
258,331
301,782
268,858
314,119
312,523
312,523314,119268,858301,782258,331249,560243,177293,177292,948292,517292,141261,573259,385219,399232,419235,594230,712229,972229,269228,430226,696226,089225,524224,910213,022212,640201,577201,198200,622190,402189,456188,622187,529186,907185,972185,231150,081138,221137,875132,467131,277125,984124,918124,348123,965123,741123,055122,108121,716121,271109,993101,976101,615101,360101,043100,829100,542100,08599,76799,29998,88298,45097,80197,03196,44396,16495,57495,01693,74691,61490,91990,08589,86585,16389,08285,16388,361101,761101,51159,18856,81656,70451,13649,49749,65249,60448,774048,51948,47747,781048,60448,70243,11143,11143,10043,00039,90039,90039,70034,60031,00030,80030,70030,60029,70029,70025,30025,30025,10025,00025,00023,80022,80022,80022,80021,000020,80017,40015,10013,90013,10010,5009,4000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue49,725
Cost of Revenue-32,929
Gross Profit16,79616,796
 
Operating Income (+$)
Gross Profit16,796
Operating Expense-71,013
Operating Income-21,288-54,217
 
Operating Expense (+$)
Research Development6,440
Selling General Administrative31,644
Selling And Marketing Expenses-
Operating Expense71,01338,084
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,220
Other Finance Cost-0
Net Interest Income-3,220
 
Pretax Income (+$)
Operating Income-21,288
Net Interest Income-3,220
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-25,035-20,761
EBIT - interestExpense = -3,220
-25,167
-21,947
Interest Expense3,220
Earnings Before Interest and Taxes (EBIT)--21,815
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-25,035
Tax Provision-132
Net Income From Continuing Ops-25,167-25,167
Net Income-25,167
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-5273,220
 

Technical Analysis of Biolase
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biolase. The general trend of Biolase is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biolase's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BIOLASE Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.07 < 1.07 < 1.27.

The bearish price targets are: 0.1251.

Tweet this
BIOLASE Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BIOLASE Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BIOLASE Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BIOLASE Inc. The current macd is -0.04831525.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biolase price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biolase. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biolase price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BIOLASE Inc Daily Moving Average Convergence/Divergence (MACD) ChartBIOLASE Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BIOLASE Inc. The current adx is 30.78.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biolase shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
BIOLASE Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BIOLASE Inc. The current sar is 0.249086.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BIOLASE Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BIOLASE Inc. The current rsi is 44.01. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
BIOLASE Inc Daily Relative Strength Index (RSI) ChartBIOLASE Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BIOLASE Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biolase price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BIOLASE Inc Daily Stochastic Oscillator ChartBIOLASE Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BIOLASE Inc. The current cci is 164.83.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
BIOLASE Inc Daily Commodity Channel Index (CCI) ChartBIOLASE Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BIOLASE Inc. The current cmo is 22.41.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BIOLASE Inc Daily Chande Momentum Oscillator (CMO) ChartBIOLASE Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BIOLASE Inc. The current willr is -49.96209249.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biolase is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BIOLASE Inc Daily Williams %R ChartBIOLASE Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BIOLASE Inc.

BIOLASE Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BIOLASE Inc. The current atr is 0.03250852.

BIOLASE Inc Daily Average True Range (ATR) ChartBIOLASE Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BIOLASE Inc. The current obv is 115,417,794.

BIOLASE Inc Daily On-Balance Volume (OBV) ChartBIOLASE Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BIOLASE Inc. The current mfi is 82.37.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
BIOLASE Inc Daily Money Flow Index (MFI) ChartBIOLASE Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BIOLASE Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

BIOLASE Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BIOLASE Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.006
Ma 20Greater thanMa 500.147
Ma 50Greater thanMa 1000.374
Ma 100Greater thanMa 2000.796
OpenGreater thanClose0.160
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biolase with someone you think should read this too:
  • Are you bullish or bearish on Biolase? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biolase? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BIOLASE Inc

I send you an email if I find something interesting about BIOLASE Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BIOLASE Inc.

Receive notifications about BIOLASE Inc in your mailbox!